Showing 1 - 3 results of 3 for search 'Kirill M Starostin' Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Author
  • Kirill M Starostin
Showing 1 - 3 results of 3 for search 'Kirill M Starostin', query time: 0.12s Refine Results
  1. 1
    Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies
    Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis o...
    by Anna A. Plyukhova, Maria V. Budzinskaya, Kirill M. Starostin, Robert Rejdak, Claudio Bucolo, Michele Reibaldi, Mario D. Toro
    Published 2020-05-01
    Get full text
    Article
  2. 2
    Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia
    Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-li...
    by Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Kirill M Starostin, Elena I Vovk, Elena N Shirokova
    Published 2020-11-01
    Get full text
    Article
  3. 3
    Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)
    Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)
    by Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Kirill M Starostin, Elena I Vovk, Elena N Shirokova
    Published 2020-11-01
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...